Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

Ko DT, Mamdani M, Alter DA.

JAMA. 2004 Apr 21;291(15):1864-70.

PMID:
15100205
2.

Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.

Chapman RH, Petrilla AA, Berman L, Benner JS, Tang SS.

Am J Cardiovasc Drugs. 2009;9(5):299-308. doi: 10.2165/11312110-000000000-00000.

PMID:
19791839
3.

Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.

Geleedst-De Vooght M, Maitland-van der Zee AH, Schalekamp T, Mantel-Teeuwisse A, Jansen P.

Drugs Aging. 2010 Jul 1;27(7):589-96. doi: 10.2165/11537330-000000000-00000.

PMID:
20583852
4.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
5.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
6.

Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A.

Br J Clin Pharmacol. 2009 Mar;67(3):355-62. doi: 10.1111/j.1365-2125.2008.03360.x. Epub 2008 Dec 10.

7.

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

van Staa TP, Smeeth L, Ng ES, Goldacre B, Gulliford M.

Heart. 2013 Nov;99(21):1597-602. doi: 10.1136/heartjnl-2013-303698. Epub 2013 Jun 4.

8.

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.

Chia YC, Lim HM, Ching SM.

BMC Fam Pract. 2014 Nov 12;15:172. doi: 10.1186/s12875-014-0172-y.

9.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

10.

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K.

Vasc Health Risk Manag. 2013;9:71-80. doi: 10.2147/VHRM.S37143. Epub 2013 Feb 21.

11.

The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002.

Teeling M, Bennett K, Feely J.

Br J Clin Pharmacol. 2005 Feb;59(2):227-32.

12.

Patterns and predictors of statin prescription in patients with type 2 diabetes.

Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

Cardiovasc Diabetol. 2009 May 13;8:25. doi: 10.1186/1475-2840-8-25.

13.

Statin use in Canadians: trends, determinants and persistence.

Neutel CI, Morrison H, Campbell NR, de Groh M.

Can J Public Health. 2007 Sep-Oct;98(5):412-6.

PMID:
17985686
15.

Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.

Wei L, MacDonald TM, Watson AD, Murphy MJ.

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):385-92.

PMID:
16998946
16.

Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.

Thornley S, Marshall R, Chan WC, Kerr A, Harrison J, Jackson G, Crengle S, Wright C, Wells S, Jackson R.

Eur J Prev Cardiol. 2012 Jun;19(3):349-57. doi: 10.1177/1741826711403069. Epub 2011 Mar 14.

PMID:
21450568
17.

Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.

Kvan E, Pettersen KI, Landmark K, Reikvam A; INPHARM study investigators.

Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):261-7.

PMID:
16315337
18.

Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery.

Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, Abela GS.

Clin Cardiol. 2013 Aug;36(8):456-61. doi: 10.1002/clc.22135. Epub 2013 May 13.

19.

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.

Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.

Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.

PMID:
19108805
20.

Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.

Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J.

Eur J Clin Pharmacol. 2005 Oct;61(9):667-74. Epub 2005 Oct 19.

PMID:
16151763
Items per page

Supplemental Content

Write to the Help Desk